By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Dangerous/banned > Phenibut

Phenibut

GMJ
Last updated: 02/06/2026 18:42
By
GMJ News Desk
Share
1 Min Read
SHARE
1 min read|90 words

Phenibut (β-phenyl-GABA) is a synthetic GABA-B agonist and voltage-dependent calcium channel blocker developed in the Soviet Union (1960s) as an anxiolytic [1]. It is a prescription drug in Russia/Eastern Europe but sold as a 'nootropic supplement' in the US/EU. Phenibut causes physical dependence rapidly (within 1–2 weeks of daily use) with a SEVERE withdrawal syndrome (anxiety, insomnia, psychosis, seizures) that can require ICU-level care. Poison control calls for phenibut have increased >900% since 2015. FDA has warned it is not a legitimate dietary ingredient [1].

Category: Dangerous/banned

Full profile pending generation.

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Federal lawsuits reveal widespread medical neglect in US immigration detention facilities

Federal lawsuits across 33 US states document allegations of medical neglect in…

Nevada’s Medical Meal Program Cuts Healthcare Costs by 11% in Medicaid Population

Nevada's medical meal delivery program reduced healthcare costs by 11% among Medicaid…

Thymus Health May Predict Longevity and Cancer Survival, AI Study Finds

AI analysis of CT scans reveals that thymus health strongly correlates with…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Mayapple / Podophyllum

By
GMJ News Desk
02/06/2026

Comfrey (oral)

By
GMJ News Desk
02/06/2026

Methylsynephrine / Oxilofrine

By
GMJ News Desk
02/06/2026

GBL (Gamma-Butyrolactone)

By
GMJ News Desk
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up